Yvonne Bombard

PhD, BSc

Scientist, Li Ka Shing Knowledge Institute

Biography

Dr. Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. She is an Assistant Professor at the University of Toronto in the Institute of Health Policy Management and Evaluation.  Her research focuses on evaluating the adoption of new genomic technologies in clinical practice. She also conducts public and patient engagement research to advance health technology assessment and health service delivery. Dr. Bombard is active in numerous international policy advisory committees; her research informs policy development in this area.  In 2014, Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research in 2011. Recently, she has been awarded a CIHR Foundation grant as an Early Career Investigator, and she holds a CIHR New Investigator Award.

Dr. Bombard holds a Fellowship from Yale University (Health Policy), a Fellowship from the Memorial Sloan-Kettering Cancer Center (Cancer Genomics) and a Fellowship from the University of Toronto (Health Services Research).

Recent Publications

  1. Bombard, Y, Rozmovits, L, Sorvari, A, Daly, C, Carroll, JC, Kennedy, E et al.. Universal tumor screening for Lynch syndrome: health-care providers' perspectives. Genet. Med. 2016; :. doi: 10.1038/gim.2016.150. PubMed PMID:27711070 .
  2. Bombard, Y, Miller, FA, Barg, CJ, Patton, SJ, Carroll, JC, Chakraborty, P et al.. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis. Genet. Med. 2016; :. doi: 10.1038/gim.2016.125. PubMed PMID:27608173 .
  3. Hayeems, RZ, Miller, FA, Barg, CJ, Bombard, Y, Kerr, E, Tam, K et al.. Parent Experience With False-Positive Newborn Screening Results for Cystic Fibrosis. Pediatrics. 2016;138 (3):. doi: 10.1542/peds.2016-1052. PubMed PMID:27485696 .
  4. Marshall, DA, Deal, K, Bombard, Y, Leighl, N, MacDonald, KV, Trudeau, M et al.. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment. BMJ Open. 2016;6 (6):e010981. doi: 10.1136/bmjopen-2015-010981. PubMed PMID:27256091 PubMed Central PMC4893875.
  5. Hayeems, RZ, Miller, FA, Barg, CJ, Bombard, Y, Cressman, C, Painter-Main, M et al.. Using Newborn Screening Bloodspots for Research: Public Preferences for Policy Options. Pediatrics. 2016;137 (6):. doi: 10.1542/peds.2015-4143. PubMed PMID:27244855 .
  6. MacDonald, KV, Bombard, Y, Deal, K, Trudeau, M, Leighl, N, Marshall, DA et al.. The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy. Eur. J. Cancer. 2016;61 :85-93. doi: 10.1016/j.ejca.2016.03.077. PubMed PMID:27155447 .
  7. Bombard, Y. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy. Genome. 2015;58 (12):491-7. doi: 10.1139/gen-2015-0145. PubMed PMID:26577841 .
  8. Dondorp, W, de Wert, G, Bombard, Y, Bianchi, DW, Bergmann, C, Borry, P et al.. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur. J. Hum. Genet. 2015;23 (11):1592. doi: 10.1038/ejhg.2015.109. PubMed PMID:26468681 PubMed Central PMC4613480.
  9. Miller, FA, Hayeems, RZ, Bombard, Y, Cressman, C, Barg, CJ, Carroll, JC et al.. Public Perceptions of the Benefits and Risks of Newborn Screening. Pediatrics. 2015;136 (2):e413-23. doi: 10.1542/peds.2015-0518. PubMed PMID:26169426 .
  10. Botkin, JR, Belmont, JW, Berg, JS, Berkman, BE, Bombard, Y, Holm, IA et al.. Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. Am. J. Hum. Genet. 2015;97 (1):6-21. doi: 10.1016/j.ajhg.2015.05.022. PubMed PMID:26140447 PubMed Central PMC4570999.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Visiting Investigator, Memorial Sloan Kettering Cancer Center, Clinical Genetics Service
  • Chair, American Society of Human Genetics’ Social Issues Committee
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Ontario Genetics Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness
  • Member, Provincial Council for Maternal and Child Health’s Maternal-Child Screening Committee
  • Chair, European Huntington Disease Network’s Discrimination Working Group (2009-2010)
  • Member, Cancer Quality Council of Ontario’s Personalized Medicine Steering Committee (2010-2011)
  • Member, Cancer Care Ontario’s Patient Experience and Performance Committee (2013-2015)
  • Member, Patient and Citizen Involvement Working Group, Health Technology Assessment International
  • Member, Ethics Working Group, Health Technology Assessment International